Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ovarian Cancer Epidemiology and Care in Brazil: A Multicenter Perspective (OLIVIA Study) Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology

NCT07167433 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07167433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ovarian Cancer Epidemiology and Care in Brazil: A Multicenter Perspective (OLIVIA Study) Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
September 19, 2025
Completion date
September 29, 2029
Enrollment
250 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer